Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG‐1942)
Shana Jacobs(Children's National), Peter C. Adamson(University College London), Frank M. Balis(National Institutes of Health), Seth M. Steinberg(National Institutes of Health), Gary R. Erdmann, Janet Franklin(Children's Hospital of Los Angeles), Joseph P. Neglia(University of Minnesota), Linda C. Stork(Oregon Health & Science University), John S. Holcenberg(Children's of Alabama), Bruce Bostrom(Minnesota West Community & Technical College), Ray Hutchinson(University of Michigan), Gregory H. Reaman(National Cancer Institute)
Cited by 27
Related Papers
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817